As of June 2024 Corcept Therapeutics has a market cap of $3.14 Billion. This makes Corcept Therapeutics the world's 3404th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.14 B | -6.18% |
2023 | $3.34 B | 53.13% |
2022 | $2.18 B | -4.36% |
2021 | $2.28 B | -24.78% |
2020 | $3.03 B | 119.26% |
2019 | $1.38 B | -9.81% |
2018 | $1.53 B | -25.44% |
2017 | $2.06 B | 155.69% |
2016 | $0.80 B | 47.63% |
2015 | $0.54 B | 79.5% |
2014 | $0.30 B | -5.1% |
2013 | $0.32 B | 124.55% |
2012 | $0.14 B | -50.45% |
2011 | $0.28 B | 3.07% |
2010 | $0.27 B | 60.92% |
2009 | $0.17 B | 242.17% |
2008 | $50.75 M | -58.46% |
2007 | $0.12 B | 286.1% |
2006 | $31.65 M | -61.7% |
2005 | $82.64 M | -41.6% |
2004 | $0.14 B |
On Jun 1st, 2024 the market cap of Corcept Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.98 B | 11,137.86% | ๐บ๐ธ USA |
Novartis NVS | $210.42 B | 6,599.25% | ๐จ๐ญ Switzerland |
Pfizer PFE | $162.40 B | 5,070.37% | ๐บ๐ธ USA |
Eli Lilly LLY | $779.65 B | 24,721.41% | ๐บ๐ธ USA |
Merck MRK | $317.96 B | 10,022.99% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $83.29 B | 2,551.77% | ๐บ๐ธ USA |
MannKind Corp MNKD | $1.27 B | -59.51% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | $0.40 B | -86.97% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $14.25 B | 353.81% | ๐บ๐ธ USA |